Niagen Bioscience, Inc. (NAGE) vs Sionna Therapeutics, Inc. (SION)

Niagen Bioscience, Inc. and Sionna Therapeutics, Inc. are both Biotechnology companies. Niagen Bioscience, Inc. and Sionna Therapeutics, Inc. are of similar size ($241.9M and $238.2M). Sionna Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Niagen Bioscience, Inc. trades at 15.2×. Niagen Bioscience, Inc. has the higher net margin (12.4% vs 0.00%) and the higher return on invested capital (42.0% vs −125.0%). Across the 12 metrics below, Niagen Bioscience, Inc. leads on 9 and Sionna Therapeutics, Inc. on 3.

Valuation

Metric NAGE SION Biotechnology median
P/E 15.20 n/m 7.88
P/S 1.87 n/m 11.47
P/B 2.92 0.89 2.52
Price to free cash flow 21.05 n/m 21.16
EV/EBITDA 15.14 n/m 0.74
EV/Sales 1.36 n/m 10.73
Earnings yield 6.58% (41.68%) (28.84%)
Free cash flow yield 4.75% (32.31%) (23.03%)

Profitability

Metric NAGE SION Biotechnology median
Gross margin 64.24% — 65.16%
Operating margin 8.21% 0.00% 0.00%
Net margin 12.39% 0.00% 0.00%
Free cash flow margin 8.89% 0.00% 0.00%
Return on equity 21.80% (32.34%) (57.72%)
Return on assets 16.14% (30.66%) (49.22%)
Return on invested capital 41.95% (125.00%) 0.00%

Growth

Metric NAGE SION Biotechnology median
Revenue growth (TTM) 10.99% — 5.64%
EPS growth (last fiscal year) 81.82% 88.24% —
Revenue growth, 5-year CAGR 16.91% — 8.40%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric NAGE SION Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 6.50 20.05 4.73
Net debt to EBITDA (3.80) 2.58 0.96

Dividend

Metric NAGE SION Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 — 0.00

Size

Metric NAGE SION Biotechnology median
Market cap 238.17m 241.89m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack